Navigation Links
Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients

atology Association (EHA), on Saturday, June 9 in Vienna, Austria.

4 Rother R, Bell L, Hillmen P, Gladwin M. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin. JAMA 2005; 293:1653-1662.

5 Parker C, Omine M, Richards S, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005; 106:3699-3709.

6 Hill A, Platts PJ, Smith A et al. The incidence and prevalence of paroxysmal nocturnal hemoglobinuria (PNH) and survival of patients in Yorkshire [abstract]. Blood. 2006;108(11):290a. Abstract 985.

7 Socie G, Mary J Yves, de Gramont A, et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. Lancet 1996; 348:573-577.

8 Hillmen P. Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995; 333:1253-1258.

9 Johnson RJ, Hillmen P. Paroxysmal nocturnal hemoglobinemia: Nature's gene therapy? J Clin Path: Mol Pathol. 2002;55:145-152.

10 Wang, et al. Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome. Blood 2002;100:3897-3902.

11 Iwanga, et al. Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes. Brit J Haem. 1998;102:465-474.

12 Maciejewski, et al. Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones. Brit J Haem. 2001;115:1015-1022

13 Hill A, Richards S, Hillmen P. Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria. British Journal of Haematology 2007; 137:3, 181-192.

14 Soliris(TM) (eculizumab) prescribing information. Alexion Pharmaceuticals, Inc., 2006.

CONTACT: Leonard Bell, M.D., Chief Executive Officer of AlexionPharmaceuticals, Inc., +1-203-272-2596; or Media, David Patti of Makovsky +Company, +1-212-508-9623, , or
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
4. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
5. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
8. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
9. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
10. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
11. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis

Post Your Comments:
(Date:11/25/2009).../PRNewswire-USNewswire/--RemediumTechnologiesInc.,...everebleeding,wonfirstprizeand$10,000intheMostProm...nge2009,companyofficialsannouncetoday. ,, Selec...um,steampitchedtheirinventionattheGSCSecuritySummi...Remedium( www.remediumtechnologies.com )isdevelopi...
(Date:11/25/2009)...Newswire-Asia-FirstCall/--ChinaSkyOne,Medical,Inc....),a,leadingfullyintegratedpharmaceuticalcompanydev...le,sRepublicofChina("PRC"),today,announcedthattheC...,theControlofPharmaceuticalandBiologicalProducts("...osticKitforHumanProstateSpecific,Antigen(Colloidal...
(Date:11/25/2009)...5/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ...ebloodanalysissystems,announcedtodaythatClintSever...the21stAnnualPiperJaffrayHealthCareConferenceonWed...lbeheldattheNewYorkPalaceHotelinNewYorkCity. ,,...dmarketsportablebloodanalysissystemsforuseinanyvet...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3New Product Detects Early Bed Bug Infestations 47675 1New Product Detects Early Bed Bug Infestations 47675 2New Product Detects Early Bed Bug Infestations 47675 3Dow AgroSciences World Wide Wheat Agree to Collaborate on Wheat 4520 1Dow AgroSciences World Wide Wheat Agree to Collaborate on Wheat 4520 2Researchers engineer metabolic pathway in mice to prevent diet induced obesity 8701 1Researchers engineer metabolic pathway in mice to prevent diet induced obesity 8701 2Researchers engineer metabolic pathway in mice to prevent diet induced obesity 8701 3
...RENCE, Italy - 8 March 2007 - Cancer drug,develope...ounces,positive initial findings from its second, ... cell lung cancer. , This 30-patient trial tested ...arboplatin and paclitaxel chemotherapy.,Investigat... of,patients showed disease stabilisation, while o...
...development program of first-in-class CB1,antagoni...tion and,avoid image as life-style drug , BARCELON...nce,firm La Merie S.L. reported today that Sanofi-...lia (rimonabant) has at least,five competitors in ...arlier phases of R&D. While Acomplia received ...
Other Medicine Technology:Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404 2Antisoma plc (UK) - Second lung cancer trial adds to positive data,on AS1404 3Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 2Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 3
(Date:11/26/2009)... get a bigger thrill when on an emotional rollerco... (HealthDay News) -- Call it the fear factor meets...s that spectators -- especially those who root for...on if it,s a closely contested match and victory w...despair. , Chew on that this Thanksgiving weeke...
(Date:11/26/2009)... Dr. David Kim of the Live Li...surgery in Dallas , is one of a growing number of ...cial networking sites to connect with individuals ...nt to fight morbid obesity. Dr. Kim is utilizing F...mation about his practice with the community. , ...
(Date:11/26/2009)... Benton Communications announ... growth system for retailers struggling to make an...WEB) November 26, 2009 -- Flu fears is the type of... the emergency room, according to Dr. David Benton...eleased business growth system – The Rfacto...
(Date:11/25/2009)..., EDINA,Minn.,Nov.25/PRNewswire-USNewswire/--Whe...st.Butachiropractorcanalsogivepatientsthehelptheyn...swhereyourjaw(mandible)contacts/connectswithyoursk...ciatedwithTMJdysfunctionarepainwithchewing,clickin...fromTMJdysfunctionincluding:headaches,fatigue,slee...
(Date:11/25/2009)..., EMERYVILLE,Calif.,Nov.25/PRNewswire-FirstCall/...nouncedthatthecompanywillhosttwoinvestoreventsinDe...09-9:00a.m.CT/10:00a.m.ET ,, Principalinvesti...lzomibinrelapsedand/orrefractorymultiplemyeloma,as...nnualMeetingandExpositioninNewOrleans,LA.Theteleco...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...ckson Lewis LLP, a leading U.S.,workplace law firm...ealth,and productivity management solutions, today...ee Jackson Lewis assist Presagia with the developm...gement is widely regarded as an effective strategy...
... to Run Ads in Heavy Rotation Through Primary, OA...al,primary vote Tuesday, the National Nurses Organ...y launched a major radio campaign across Ohio with...io ad is running in markets across the state,inclu...
...d arthritis (RA) is more predominant in women, the...xamined the effects of estrogen on the risk and se...controversial. A new study using data from the Wom...RA or the severity of RA between postmenopausal wo...
...r US Firefighter Scott Ellis for His Comeback from...er Robert Hill on Everest ...s, a firefighter from,Enfield, Connecticut was nam...and ulcerative colitis patient Rolf,Benirschke, th...
...icester scientist has announced a major advance in... and young children. , The Leicestershire and Rut...ating its 5th anniversary, has now made funding av... the Universitys Department of Cancer Studies and ...
...Feb. 27 Boca Pharmacal, Inc.,announced today that...,final approval for the Company,s Abbreviated New ...ion of Pamlab,s Palgic(R) Oral Solution,(Carbinoxa...to treat,seasonal and perennial allergic rhinitis....
Other Medicine News:Health News:Jackson Lewis to Support Presagia's Integrated Absence & Disability Management Solution 2Health News:Nurses Launch Major Ohio Radio Ad Campaign Telling Candidates: Stop Selling Insurance and Back Real Reform 2Health News:Nurses Launch Major Ohio Radio Ad Campaign Telling Candidates: Stop Selling Insurance and Back Real Reform 3Health News:Hormone replacement therapy appears to have no effect on risk and severity of rheumatoid arthritis 2Health News:Great Comebacks(R) Program Announces 2007 National Award Winner 2Health News:Great Comebacks(R) Program Announces 2007 National Award Winner 3Health News:Great Comebacks(R) Program Announces 2007 National Award Winner 4Health News:Great Comebacks(R) Program Announces 2007 National Award Winner 5Health News:Leicester scientist announces 'unexpected and exciting advance' in study of cancer type 2
Lyophilized Lipid Control
Fibrinogen Control
MONO Mononucleosis Rapid Test Device
...EZ Flu A+B test is a rapid chromatographic immunoa...nfluenza A and B viral antigens from nasopharyngea... patients. The Directigen EZ Flu A+B test is a dif...gens can be distinguished from influenza B viral a...
Medicine Products: